InvestorsHub Logo
Followers 65
Posts 3758
Boards Moderated 0
Alias Born 03/22/2020

Re: None

Sunday, 08/08/2021 4:00:28 PM

Sunday, August 08, 2021 4:00:28 PM

Post# of 118383
One paragraph says it all about RGBPs patents. RGBP is ahead of the field on this one.

Future mRNA vaccine technology may allow for one vaccine to provide protection for multiple diseases, thus decreasing the number of shots needed for protection against common vaccine-preventable diseases.

Beyond vaccines, cancer research has used mRNA to trigger the immune system to target specific cancer cells.